Kadri Kangro

1.0k total citations · 1 hit paper
16 papers, 556 citations indexed

About

Kadri Kangro is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Kadri Kangro has authored 16 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Hematology and 5 papers in Genetics. Recurrent topics in Kadri Kangro's work include Complement system in diseases (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Kadri Kangro is often cited by papers focused on Complement system in diseases (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Kadri Kangro collaborates with scholars based in Belgium, Netherlands and France. Kadri Kangro's co-authors include Mart Ustav, Kai Kisand, Paul Naaber, Liis Haljasmägi, Anu Planken, Epp Sepp, Jaanika Kärner, Pärt Peterson, Liina Tserel and Regina Maruste and has published in prestigious journals such as Blood, Analytical Chemistry and Thrombosis and Haemostasis.

In The Last Decade

Kadri Kangro

16 papers receiving 550 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study

2021 379 citations Paul Naaber, Liina Tserel et al. The Lancet Regional Health - Europe profile →

Peers

Countries citing papers authored by Kadri Kangro

Since Specialization

Citations

This map shows the geographic impact of Kadri Kangro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kadri Kangro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kadri Kangro more than expected).

Fields of papers citing papers by Kadri Kangro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kadri Kangro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kadri Kangro. The network helps show where Kadri Kangro may publish in the future.

Co-authorship network of co-authors of Kadri Kangro

This figure shows the co-authorship network connecting the top 25 collaborators of Kadri Kangro. A scholar is included among the top collaborators of Kadri Kangro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kadri Kangro. Kadri Kangro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Plasminogen activation and plasmin activity are not necessary to prevent venous thrombosis/thromboembolism 2025 ·Blood ·Yaqiu Sang, Marzia Menegatti, Jennifer A. Brody, Kerri L. Wiggins, (unknown), (unknown), Kadri Kangro, Bas de Laat, Flora Peyvandi, Matthew J. Flick, Nicholas H. Smith, Amy D. Shapiro, Alisa S. Wolberg	1
2	Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration 2023 ·Blood ·James R. Byrnes, (unknown), (unknown), Robert A. Campbell, (unknown), Lori A. Holle, Michelle Luo, Kadri Kangro, Jonathon W. Homeister, Maria M. Aleman, James P. Luyendyk, Bryce A. Kerlin, Julie B. Dumond, Alisa S. Wolberg	5
3	Improvement of recombinant ADAMTS13 production through a more optimal signal peptide or an N‐terminal fusion protein 2022 ·Journal of Thrombosis and Haemostasis ·Kadri Kangro, Elien Roose, (unknown), Aline Vandenbulcke, (unknown), Jan Voorberg, Mart Ustav, Andres Männik, Karen Vanhoorelbeke	2
4	Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine 2022 ·Cell Reports Medicine ·Paul Naaber, Liina Tserel, Kadri Kangro, (unknown), Epp Sepp, (unknown), Jaanika Kärner, Liis Haljasmägi, Uku Haljasorg, (unknown), (unknown), Anu Planken, Mart Ustav, Eva Žusinaite, (unknown), Kai Kisand, Pärt Peterson	15
5	Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19 2022 ·Current Drug Targets ·Matthew J. Flick, Kadri Kangro, Alisa S. Wolberg	26
6	N-glycan–mediated shielding of ADAMTS13 prevents binding of pathogenic autoantibodies in immune-mediated TTP 2021 ·Blood ·(unknown), (unknown), Kadri Kangro, (unknown), Kanin Wichapong, (unknown), Paul Kaijen, Floris P. J. van Alphen, Maartje van den Biggelaar, Karen Vanhoorelbeke, Agnès Veyradier, Paul Coppo, Chris Reutelingsperger, Gerry A. F. Nicolaes, Andres Männik, Jan Voorberg	13
7	Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study breakdown → 2021 ·The Lancet Regional Health - Europe ·Paul Naaber, Liina Tserel, Kadri Kangro, Epp Sepp, (unknown), (unknown), Liis Haljasmägi, Pauliina Rumm, Regina Maruste, Jaanika Kärner, (unknown), Anu Planken, Mart Ustav, Kai Kisand, Pärt Peterson	379
8	Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP 2021 ·Blood Advances ·(unknown), Aurore Curie, Kadri Kangro, Edwige Tellier, Gilles Kaplanski, Andres Männik, Claudia Tersteeg, Bérangère S. Joly, Paul Coppo, Agnès Veyradier, Simon F. De Meyer, Elien Roose, Karen Vanhoorelbeke	10
9	Determination of anti‐ADAMTS‐13 autoantibody titers in ELISA: Influence of ADAMTS‐13 presentation and autoantibody detection 2021 ·Journal of Thrombosis and Haemostasis ·(unknown), Elien Roose, Kadri Kangro, (unknown), Aline Vandenbulcke, Edwige Tellier, Gilles Kaplanski, Hendrik B. Feys, Claudia Tersteeg, Andres Männik, Simon F. De Meyer, Karen Vanhoorelbeke	9
10	Evaluation of Immuno-Rolling Circle Amplification for Multiplex Detection and Profiling of Antigen-Specific Antibody Isotypes 2021 ·Analytical Chemistry ·(unknown), Felix Neumann, (unknown), Christoffer Mattsson Langseth, Kadri Kangro, (unknown), Narayanan Madaboosi, Nick Geukens, Karen Vanhoorelbeke, Mats Nilsson, Jeroen Lammertyn	17
11	Declined Antibody Responses to COVID-19 mRNA Vaccine within First Three Months 2021 ·SSRN Electronic Journal ·Paul Naaber, Liina Tserel, Kadri Kangro, Epp Sepp, (unknown), (unknown), Liis Haljasmägi, Pauliina Rumm, Regina Maruste, Jaanika Kärner, (unknown), Anu Planken, Mart Ustav, Kai Kisand, Pärt Peterson	2
12	Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura 2021 ·Blood Advances ·Kadri Kangro, Elien Roose, Bérangère S. Joly, György Sinkovits, Tanja Falter, Charis von Auer, Heidi Rossmann, Marienn Réti, Jan Voorberg, Zoltán Prohászka, Bernhard Lämmle, Paul Coppo, Agnès Veyradier, Simon F. De Meyer, Andres Männik, Karen Vanhoorelbeke	15
13	Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura 2020 ·Research and Practice in Thrombosis and Haemostasis ·Kadri Kangro, Elien Roose, (unknown), Edwige Tellier, Gilles Kaplanski, Jan Voorberg, Simon F. De Meyer, Andres Männik, Karen Vanhoorelbeke	12
14	Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic Purpura 2020 ·HemaSphere ·(unknown), (unknown), Kadri Kangro, Matthieu Jamme, Sandrine Malot, Lionel Galicier, Pascale Poullin, François Provôt, Claire Presne, Tarik Kanouni, Aude Servais, Y. Benhamou, Nicolas Daguindau, Karen Vanhoorelbeke, Élie Azoulay, Agnès Veyradier, Paul Coppo	4
15	Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura 2019 ·Haematologica ·(unknown), (unknown), (unknown), Kadri Kangro, Paul Kaijen, Gerry A. F. Nicolaes, Agnès Veyradier, Paul Coppo, Karen Vanhoorelbeke, Andres Männik, Jan Voorberg	19
16	Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura 2018 ·Thrombosis and Haemostasis ·Elien Roose, Gestur Vidarsson, Kadri Kangro, O. J. H. M. Verhagen, Ilaria Mancini, Linda Desender, Inge Pareyn, Nele Vandeputte, Aline Vandenbulcke, Chiara Vendramin, An‐Sofie Schelpe, Jan Voorberg, (unknown), Laurent Gilardin, Marie Scully, Daan Dierickx, Hans Deckmyn, Simon F. De Meyer, Flora Peyvandi, Karen Vanhoorelbeke	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact